We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$36.4M
Cap. Flow
+$97.7M
Cap. Flow %
6.05%
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19

Top Buys

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$22.6M
2
MSFT icon
Microsoft
MSFT
+$12.4M
3
AAPL icon
Apple
AAPL
+$9.73M
4
NVDA icon
NVIDIA
NVDA
+$9.56M
5
AMZN icon
Amazon
AMZN
+$6.91M

Top Sells

Rank Stock Value
1
SE icon
Sea Limited
SE
+$20.8M
2
AMD icon
Advanced Micro Devices
AMD
+$16.3M
3
TSM icon
TSMC
TSM
+$7.3M
4
PDD icon
Pinduoduo
PDD
+$2.71M
5
WB icon
Weibo
WB
+$2.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.2%
2 Technology 29.79%
3 Communication Services 9.9%
4 Healthcare 5.71%
5 Real Estate 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCKT icon
201
Rocket Pharmaceuticals
RCKT
$424M
$419K 0.03%
15,549
+4,352
+39% +$124K
SWTX
202
DELISTED
SpringWorks Therapeutics
SWTX
$418K 0.03%
8,486
+734
+9% +$33.9K
IDYA icon
203
IDEAYA Biosciences
IDYA
$3.87B
$417K 0.03%
9,512
-873
-8% -$37.5K
ACLX
204
DELISTED
Arcellx
ACLX
$416K 0.03%
5,986
-26
-0.4% -$1.65K
FOLD
205
DELISTED
Amicus Therapeutics
FOLD
$415K 0.03%
35,232
-7,316
-17% -$93.6K
APLS
206
DELISTED
Apellis Pharmaceuticals
APLS
$413K 0.03%
7,032
-625
-8% -$39.8K
IT icon
207
Gartner
IT
$12.5B
$411K 0.03%
862
-15
-2% -$6.9K
SMCI icon
208
Super Micro Computer
SMCI
$24B
$410K 0.03%
+4,060
New +$297K
UTHR icon
209
United Therapeutics
UTHR
$22.1B
$410K 0.03%
1,783
-205
-10% -$46.3K
DVAX
210
DELISTED
Dynavax Technologies
DVAX
$409K 0.03%
32,980
+3,964
+14% +$51.7K
IOVA icon
211
Iovance Biotherapeutics
IOVA
$3.63B
$409K 0.03%
27,602
-39,136
-59% -$456K
BHVN icon
212
Biohaven
BHVN
$2.33B
$409K 0.03%
7,476
-7,052
-49% -$349K
PCVX icon
213
Vaxcyte
PCVX
$8.9B
$407K 0.03%
5,962
-2,514
-30% -$174K
PVH icon
214
PVH
PVH
$3.49B
$406K 0.03%
+2,888
New +$370K
PTCT icon
215
PTC Therapeutics
PTCT
$5.85B
$405K 0.03%
13,908
-4,280
-24% -$120K
KDP icon
216
Keurig Dr Pepper
KDP
$43.8B
$403K 0.03%
13,145
-249
-2% -$7.67K
ALKS icon
217
Alkermes
ALKS
$7.95B
$401K 0.02%
14,816
-3,757
-20% -$107K
KYMR icon
218
Kymera Therapeutics
KYMR
$9.82B
$401K 0.02%
+9,965
New +$357K
RARE icon
219
Ultragenyx Pharmaceutical
RARE
$2.52B
$400K 0.02%
8,577
-3,294
-28% -$155K
NTLA icon
220
Intellia Therapeutics
NTLA
$1.8B
$398K 0.02%
14,460
-2,091
-13% -$58.1K
FANG icon
221
Diamondback Energy
FANG
$55.4B
$398K 0.02%
2,006
+223
+13% +$37.9K
TWST icon
222
Twist Bioscience
TWST
$8.87B
$396K 0.02%
11,535
-748
-6% -$27K
ILMN icon
223
Illumina
ILMN
$32.6B
$395K 0.02%
2,956
-17
-0.6% -$2.28K
TGTX icon
224
TG Therapeutics
TGTX
$8.26B
$393K 0.02%
25,826
-4,727
-15% -$75.3K
CHTR icon
225
Charter Communications
CHTR
$18.3B
$393K 0.02%
1,351
-58
-4% -$18.6K
7 8
9
10 11

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q1 2024 Portfolio in Review

As of Q1 2024, E Fund Management held 387 positions worth $1.61B, up 2.3% from $1.58B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

E Fund Management deployed $97.7M of net new capital in Q1 2024, opening 81 new positions and adding to 131 existing holdings. Its largest new stake was ASE Group: 2,300,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 50% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Sea Limited, an estimated $20.8M trimmed.

  • E Fund Management's largest Q1 2024 buy was ASE Group: 2,300,000 shares worth $25.3M.
  • E Fund Management added most to Microsoft in Q1 2024, an estimated $12.4M increase.
  • E Fund Management's biggest Q1 2024 reduction was Sea Limited, cutting an estimated $20.8M.
  • E Fund Management fully exited Hesai Group in Q1 2024, selling an estimated $1.52M.
  • E Fund Management's ten largest holdings make up 61% of its $1.61B portfolio in Q1 2024.
  • E Fund Management opened 81 new positions and closed 19 in Q1 2024.
  • E Fund Management's portfolio value rose 2.3% quarter-over-quarter to $1.61B.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.